Becton, Dickinson and Co. | BDX - Stock


Becton, Dickinson and Co. reported $3.36B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Agilent USD 1.09B 30M Mar/2026
Align Technology USD 214.94M 11.4M Mar/2026
AngioDynamics USD 65.57M 3.56M Sep/2025
Avanos Medical USD 141.3M 6.7M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Bio-Rad Laboratories USD 770.5M 29.8M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
Cooper Companies USD 876.4M 30.4M Dec/2025
Danaher USD 2.61B 119M Mar/2026
Dentsply International USD 659M 17M Mar/2026
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Globus Medical USD 772.6M 13.32M Mar/2026
Insulet USD 462.5M 9.9M Mar/2026
Integra LifeSciences USD 495.04M 2.3M Mar/2026
Intuitive Surgical USD 1.95B 105.1M Mar/2026
J&J USD 14.58B 392M Mar/2026
Masimo USD 400M 61.4M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Solventum Corp USD 1.09B 23M Mar/2026
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 126.4M 2.37M Mar/2026
Teleflex USD 380.86M 23.53M Mar/2026
Terumo JPY 311.91B 10.92B Sep/2025
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026